As of February 2025 Viracta Therapeutics has a market cap of €1.13 Million. This makes Viracta Therapeutics the world's 10338th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.